Immunocore Holdings PLC expected to post a loss of 22 pence a share - Earnings Preview
26/02/2024 14:14
* Immunocore Holdings PLC IMCR.OQ IMCR.O is expected
to show a
rise in quarterly revenue when it reports results on February
28 for the period ending December 31 2023
* The Abingdon Oxfordshire-based company is expected to
report a
11.0% increase in revenue to £53.325 million from £48.06 million
a year ago, according to the mean estimate from 16 analysts,
based on LSEG data. (sales is on Total Revenue basis)
* LSEG's mean analyst estimate for Immunocore Holdings PLC
is for
a loss of 22 pence per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 16 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Immunocore
Holdings PLC is $84.00, above its last closing price
of $69.86.
Previous quarterly performance (using preferred earnings measure
in pounds).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.29 -0.29 0.04 Beat 113.8
Jun. 30 2023 -0.31 -0.32 -0.29 Beat 9.7
Mar. 31 2023 -0.36 -0.32 -0.35 Missed -10.7
Dec. 31 2022 -0.01 0.00 -0.54 Missed -2,523
,264.5
Sep. -0.22 -0.29 0.12 Beat 141.7
30 2022
Jun. 30 2022 -0.59 -0.67 -0.14 Beat 79.1
Mar. 31 2022 -0.82 -0.84 -0.37 Beat 56.2
Dec. 31 2021 -0.80 -0.82 -0.91 Missed -10.9
This summary was machine generated February 26 at 14:14 GMT.
All figures in pounds unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)